Vous êtes ici

Xtacy Therapeutics Corp.

Xtacy Therapeutics Corp.
Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Diversified Industries
Symbole: 
XTCY
Indice CSE: 
Devise: 

Xtacy Therapeutics Corp is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast-growing market for wellness consumer products. The present focus of the company is in hemp and CBD-related, psilocybin and functional mushrooms, and health-care related industries.

Vous êtes ici

Xtacy Therapeutics Corp. (XTCY)

SEDAR Information

Information d'entreprise

Addresse
1100 - 1111 Melville St
Vancouver, BC V3E 3V6
Canada
Téléphone
6042836110
Courriel
[email protected]
URL
https://xtacytherapeutics.com/
Date d’inscription à la cote
Jeudi, juillet 16, 2009
Agent de transfert
Computershare Investor Services Inc.
Relations avec les investisseurs
604-245-5974
Courriel
[email protected]
Vérificateur
SHIM & Associates LLP

Capitalisation

Capitalisation: 
54576471
Réservé à l'émission: 
3363890

Company Officers

Meris Kott, Director, CEO
Lindsey Perry Jr., Director and CFO
Ashleigh Vogstad, Director

Bulletins

25/09/2023

2023-0929 - Changement de Nom et de Symbole - Global Wellness Strategies Inc. (GWS)

le 25 septembre/September 2023

Global Wellness Strategies Inc. (GWS) has announced a name and symbol change to Xtacy Therapeutics Corp. (XTCY)

Shares will begin trading under the new name and symbol and with a new CUSIP number on September 26, 2023.

Disclosure documents are available at www.thecse.com.